FDA Draft Guidance Will Aim To Increase CLIA Waiver Flexibility
This article was originally published in The Gray Sheet
Executive Summary
FDA plans to release a CLIA waiver draft guidance by year end, according to the Office of In Vitro Diagnostic Devices Evaluation & Safety